AtriCure, Inc. (ATRC) · Insider trading
What AtriCure's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$4.37M
8 insiders, 20% under a plan
Net, 12 months
−$4.37M
bought less sold
Latest filing
2026-09-24
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Wehrwein SvenDirector | – | $1.69M | 5 | 2026-07-28 | 40,518 |
| Privitera SalvatoreChief Technical Officer | – | $879,832 | 3 | 2026-09-23 | 142,745 |
| Doraiswamy VinayakChief Scientific Officer | – | $698,130 | 5 | 2026-07-28 | 86,511 |
| Noznesky Justin JChief Mktg & Strategy Officer | – | $541,402 | 3 | 2026-07-29 | 100,219 |
| Dahlquist Karl S.Chief Legal Officer | – | $458,099 | 1 | 2026-08-24 | 87,319 |
| Prange KarenDirector | – | $456,765 | 3 | 2026-08-05 | 22,809 |
| Groves Regina eDirector | – | $378,354 | 2 | 2026-09-11 | 34,546 |
| Yuen MaggieDirector | – | $241,630 | 2 | 2026-08-05 | 14,015 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Privitera SalvatoreChief Technical Officer | Saleplan | 4,519 | 60.00 | $271,140 | 142,745 | Form 4 |
| 2026-09-11 | Groves Regina eDirector | Sale | 5,313 | 54.22 | $288,071 | 34,546 | Form 4 |
| 2026-09-08 | Privitera SalvatoreChief Technical Officer | Saleplan | 3,657 | 55.00 | $201,135 | 147,264 | Form 4 |
| 2026-09-02 | Privitera SalvatoreChief Technical Officer | Saleplan | 7,763 | 52.50 | $407,558 | 150,921 | Form 4 |
| 2026-08-24 | Dahlquist Karl S.Chief Legal Officer | Sale | 9,370 | 48.89 | $458,099 | 87,319 | Form 4 |
| 2026-08-05 | Prange KarenDirector | Sale | 3,564 | 38.80 | $138,283 | 22,809 | Form 4 |
| 2026-08-05 | Yuen MaggieDirector | Sale | 3,500 | 38.42 | $134,470 | 14,015 | Form 4 |
| 2026-07-29 | Noznesky Justin JChief Mktg & Strategy Officer | Sale | 6,182 | 38.80 | $239,862 | 100,219 | Form 4 |
| 2026-07-28 | Wehrwein SvenDirector | Sale | 25,000 | 37.84 | $946,000 | 40,518 | Form 4 |
| 2026-07-28 | Doraiswamy VinayakChief Scientific Officer | Sale | 6,000 | 38.88 | $233,280 | 86,511 | Form 4 |
| 2026-05-20 | Prange KarenDirector | Sale | 3,000 | 28.65 | $85,950 | 26,373 | Form 4 |
| 2026-05-15 | Doraiswamy VinayakChief Scientific Officer | Sale | 5,000 | 28.13 | $140,650 | 91,875 | Form 4 |
| 2026-03-12 | Doraiswamy VinayakChief Scientific Officer | Sale | 5,000 | 29.83 | $149,150 | 96,875 | Form 4 |
| 2025-11-26 | Noznesky Justin JChief Mktg & Strategy Officer | Sale | 5,166 | 37.29 | $192,640 | 78,798 | Form 4 |
| 2025-11-25 | Wehrwein SvenDirector | Sale | 4,967 | 38.00 | $188,746 | 34,374 | Form 4 |
| 2025-11-24 | Wehrwein SvenDirector | Sale | 5,033 | 37.32 | $187,832 | 34,374 | Form 4 |
| 2025-11-21 | Yuen MaggieDirector | Sale | 3,000 | 35.72 | $107,160 | 11,371 | Form 4 |
| 2025-09-12 | Noznesky Justin JChief Mktg & Strategy Officer | Sale | 3,000 | 36.30 | $108,900 | 83,964 | Form 4 |
| 2025-08-22 | Wehrwein SvenDirector | Sale | 5,000 | 37.00 | $185,000 | 34,374 | Form 4 |
| 2025-08-19 | Wehrwein SvenDirector | Sale | 5,000 | 36.00 | $180,000 | 34,374 | Form 4 |
| 2025-08-06 | Groves Regina eDirector | Sale | 2,452 | 36.82 | $90,283 | 33,715 | Form 4 |
| 2025-08-05 | Doraiswamy VinayakChief Scientific Officer | Sale | 2,500 | 36.58 | $91,450 | 71,872 | Form 4 |
| 2025-05-28 | Doraiswamy VinayakChief Scientific Officer | Sale | 2,500 | 33.44 | $83,600 | 73,550 | Form 4 |
| 2025-03-05 | Prange KarenDirector | Sale | 6,100 | 38.12 | $232,532 | 17,828 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
56 × grant or award15 × shares withheld for tax9 × gift7 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-30 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −700 | – | 778,434 | Form 4 |
| 2026-07-30 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −4,000 | – | 774,434 | Form 4 |
| 2026-07-28 | Wehrwein SvenDirector | Option exercise M | +25,000 | 19.95 | 65,518 | Form 4 |
| 2026-06-30 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +636 | 23.78 | 779,134 | Form 4 |
| 2026-06-30 | Privitera SalvatoreChief Technical Officer | Grant or award A | +636 | 23.78 | 158,684 | Form 4 |
| 2026-06-30 | Seith Douglas JChief Operating Officer | Grant or award A | +527 | 23.78 | 229,867 | Form 4 |
| 2026-06-30 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +636 | 23.78 | 96,689 | Form 4 |
| 2026-06-30 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +636 | 23.78 | 92,511 | Form 4 |
| 2026-05-18 | Wehrwein SvenDirector | Grant or award A | +6,144 | – | 40,518 | Form 4 |
| 2026-05-18 | Johnson B KristineDirector | Grant or award A | +6,144 | – | 55,954 | Form 4 |
| 2026-05-18 | Prange KarenDirector | Grant or award A | +6,144 | – | 29,373 | Form 4 |
| 2026-05-18 | White Robert S.Director | Grant or award A | +6,144 | – | 128,318 | Form 4 |
| 2026-05-18 | Groves Regina eDirector | Grant or award A | +6,144 | – | 39,859 | Form 4 |
| 2026-05-18 | Yuen MaggieDirector | Grant or award A | +6,144 | – | 17,515 | Form 4 |
| 2026-05-18 | Telman Deborah HDirector | Grant or award A | +6,144 | – | 28,328 | Form 4 |
| 2026-05-18 | Nachman ShlomoDirector | Grant or award A | +6,144 | – | 24,655 | Form 4 |
| 2026-03-10 | White Robert S.Director | Option exercise M | +10,000 | 14.99 | 122,174 | Form 4 |
| 2026-03-06 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −5,000 | – | 779,498 | Form 4 |
| 2026-03-06 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −1,000 | – | 778,498 | Form 4 |
| 2026-03-01 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +68,618 | – | 755,995 | Form 4 |
| 2026-03-01 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +101,280 | – | 857,275 | Form 4 |
| 2026-03-01 | Carrel Michael HDirector, President, CEO, & Director | Shares withheld for tax F | −72,777 | 31.26 | 784,498 | Form 4 |
| 2026-03-01 | Privitera SalvatoreChief Technical Officer | Grant or award A | +30,390 | – | 155,977 | Form 4 |
| 2026-03-01 | Privitera SalvatoreChief Technical Officer | Grant or award A | +15,198 | – | 171,175 | Form 4 |
| 2026-03-01 | Privitera SalvatoreChief Technical Officer | Shares withheld for tax F | −13,127 | 31.26 | 158,048 | Form 4 |
| 2026-03-01 | Seith Douglas JChief Operating Officer | Grant or award A | +42,386 | – | 226,756 | Form 4 |
| 2026-03-01 | Seith Douglas JChief Operating Officer | Grant or award A | +25,532 | – | 252,288 | Form 4 |
| 2026-03-01 | Seith Douglas JChief Operating Officer | Shares withheld for tax F | −22,948 | 31.26 | 229,340 | Form 4 |
| 2026-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Grant or award A | +27,991 | – | 106,789 | Form 4 |
| 2026-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Grant or award A | +15,198 | – | 121,987 | Form 4 |
| 2026-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Shares withheld for tax F | −15,586 | 31.26 | 106,401 | Form 4 |
| 2026-03-01 | Wirick Angela LChief Financial Officer | Grant or award A | +39,987 | – | 204,757 | Form 4 |
| 2026-03-01 | Wirick Angela LChief Financial Officer | Grant or award A | +23,101 | – | 227,858 | Form 4 |
| 2026-03-01 | Wirick Angela LChief Financial Officer | Shares withheld for tax F | −22,965 | 31.26 | 204,893 | Form 4 |
| 2026-03-01 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +27,991 | – | 96,542 | Form 4 |
| 2026-03-01 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +15,198 | – | 111,740 | Form 4 |
| 2026-03-01 | Dahlquist Karl S.Chief Legal Officer | Shares withheld for tax F | −15,687 | 31.26 | 96,053 | Form 4 |
| 2026-03-01 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +30,390 | – | 102,262 | Form 4 |
| 2026-03-01 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +15,198 | – | 117,460 | Form 4 |
| 2026-03-01 | Doraiswamy VinayakChief Scientific Officer | Shares withheld for tax F | −15,585 | 31.26 | 101,875 | Form 4 |
| 2025-12-31 | Seith Douglas JChief Operating Officer | Grant or award A | +257 | 27.37 | 184,370 | Form 4 |
| 2025-12-10 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −4,000 | – | 687,377 | Form 4 |
| 2025-11-25 | Wehrwein SvenDirector | Option exercise M | +4,967 | 19.95 | 39,341 | Form 4 |
| 2025-11-24 | Wehrwein SvenDirector | Option exercise M | +5,033 | 19.95 | 39,407 | Form 4 |
| 2025-11-13 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −6,000 | – | 691,377 | Form 4 |
| 2025-08-22 | Wehrwein SvenDirector | Option exercise M | +5,000 | 19.95 | 39,374 | Form 4 |
| 2025-08-19 | Wehrwein SvenDirector | Option exercise M | +5,000 | 19.95 | 39,374 | Form 4 |
| 2025-08-08 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −10,000 | – | 697,377 | Form 4 |
| 2025-06-30 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +822 | 25.84 | 68,551 | Form 4 |
| 2025-06-30 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +822 | 25.84 | 707,377 | Form 4 |
| 2025-06-30 | Privitera SalvatoreChief Technical Officer | Grant or award A | +822 | 25.84 | 125,587 | Form 4 |
| 2025-06-30 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +822 | 25.84 | 74,372 | Form 4 |
| 2025-06-30 | Seith Douglas JChief Operating Officer | Grant or award A | +550 | 25.84 | 184,113 | Form 4 |
| 2025-05-19 | Groves Regina eDirector | Grant or award A | +5,401 | – | 36,167 | Form 4 |
| 2025-05-19 | Telman Deborah HDirector | Grant or award A | +5,401 | – | 22,184 | Form 4 |
| 2025-05-19 | Wehrwein SvenDirector | Grant or award A | +5,401 | – | 34,374 | Form 4 |
| 2025-05-19 | Johnson B KristineDirector | Grant or award A | +5,401 | – | 49,810 | Form 4 |
| 2025-05-19 | Nachman ShlomoDirector | Grant or award A | +5,401 | – | 18,511 | Form 4 |
| 2025-05-19 | Prange KarenDirector | Grant or award A | +5,401 | – | 23,229 | Form 4 |
| 2025-05-19 | White Robert S.Director | Grant or award A | +5,401 | – | 112,174 | Form 4 |
| 2025-05-19 | Yuen MaggieDirector | Grant or award A | +5,401 | – | 14,371 | Form 4 |
| 2025-05-05 | White Robert S.Director | Option exercise M | +10,000 | 22.62 | 106,773 | Form 4 |
| 2025-03-10 | Carrel Michael HDirector, President, CEO, & Director | Gift G | −4,000 | – | 706,555 | Form 4 |
| 2025-03-01 | Wirick Angela LChief Financial Officer | Grant or award A | +30,330 | – | 169,400 | Form 4 |
| 2025-03-01 | Wirick Angela LChief Financial Officer | Grant or award A | +9,003 | – | 178,403 | Form 4 |
| 2025-03-01 | Wirick Angela LChief Financial Officer | Shares withheld for tax F | −13,633 | 38.74 | 164,770 | Form 4 |
| 2025-03-01 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +19,359 | – | 71,020 | Form 4 |
| 2025-03-01 | Dahlquist Karl S.Chief Legal Officer | Grant or award A | +6,579 | – | 77,599 | Form 4 |
| 2025-03-01 | Dahlquist Karl S.Chief Legal Officer | Shares withheld for tax F | −9,870 | 38.74 | 67,729 | Form 4 |
| 2025-03-01 | Yount Deborah LeeChief Human Resources Officer | Grant or award A | +14,853 | – | 57,539 | Form 4 |
| 2025-03-01 | Yount Deborah LeeChief Human Resources Officer | Shares withheld for tax F | −11,961 | 38.74 | 45,578 | Form 4 |
| 2025-03-01 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +50,335 | – | 703,574 | Form 4 |
| 2025-03-01 | Carrel Michael HDirector, President, CEO, & Director | Grant or award A | +50,907 | – | 754,481 | Form 4 |
| 2025-03-01 | Carrel Michael HDirector, President, CEO, & Director | Shares withheld for tax F | −43,926 | 38.74 | 710,555 | Form 4 |
| 2025-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Grant or award A | +19,359 | – | 90,058 | Form 4 |
| 2025-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Grant or award A | +6,579 | – | 96,637 | Form 4 |
| 2025-03-01 | Noznesky Justin JChief Mktg & Strategy Officer | Shares withheld for tax F | −9,673 | 38.74 | 86,964 | Form 4 |
| 2025-03-01 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +19,359 | – | 79,143 | Form 4 |
| 2025-03-01 | Doraiswamy VinayakChief Scientific Officer | Grant or award A | +6,579 | – | 85,722 | Form 4 |
| 2025-03-01 | Doraiswamy VinayakChief Scientific Officer | Shares withheld for tax F | −9,672 | 38.74 | 76,050 | Form 4 |
| 2025-03-01 | Privitera SalvatoreChief Technical Officer | Grant or award A | +22,586 | – | 126,583 | Form 4 |
| 2025-03-01 | Privitera SalvatoreChief Technical Officer | Grant or award A | +6,579 | – | 133,162 | Form 4 |
| 2025-03-01 | Privitera SalvatoreChief Technical Officer | Shares withheld for tax F | −8,397 | 38.74 | 124,765 | Form 4 |
| 2025-03-01 | Seith Douglas JChief Operating Officer | Grant or award A | +32,266 | – | 186,493 | Form 4 |
| 2025-03-01 | Seith Douglas JChief Operating Officer | Grant or award A | +12,120 | – | 198,613 | Form 4 |
| 2025-03-01 | Seith Douglas JChief Operating Officer | Shares withheld for tax F | −15,050 | 38.74 | 183,563 | Form 4 |
| 2024-12-11 | Noznesky Justin JChief Mktg & Strategy Officer | Gift G | −585 | – | 70,699 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.